The external advisory board will work with the hospital to select promising technologies for development and, along with the investigators, generate a specific project plan. The hospital will then engage CROs to carry out the plan-which cannot typically be done in a hospital environment. To insure that milestones are being adequately met, the hospital also intends to take an active role in managing the awarded projects. The newly appointed Technology Development Manager, Monique Yoakim-Turk, Ph.D., will work with members of the advisory board who will play a mentorship role to selected projects--coordinating the projects, communication and deliverables between the hospital, the investigators and the CROs.
Collaborations and licenses through Children's Technology and Innovation Development Office (formerly the Intellectual Property Office) have produced nine major products that are now on the market, including a medical device to close holes in the heart and two anti-cancer therapies. In 2008, research funding at Children's Hospital Boston totaled over $180 million and TIDO received 116 Invention disclosures and executed 20 licensing and 37sponsored research and clinical trial agreements with industry.
The Children's Hospital Boston Technology Development Fund Advisory Board includes:
Dean Banks, MBA, CEO Connective Orthopeadics
Alan Crane, MBA, Venture partner, Polaris Venture Partners
Russ Granzow, VP Strategic Business Dev, Philips
Stanley N. Lapidus, Director/Founder/Chairman of the Board, Helicos Biosciences Corp
Larry Miller, MD, Founding Partne
Copyright©2009 Vocus, Inc.
All rights reserved